Package 50242-041-10

Brand: cathflo activase

Generic: alteplase
NDC Package

Package Facts

Identity

Package NDC 50242-041-10
Digits Only 5024204110
Product NDC 50242-041
Product ID 50242-041_0c2938dd-2978-411f-bd76-208fc8754838
Description

10 VIAL in 1 CARTON (50242-041-10) / 2 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2019-10-14
Brand cathflo activase
Generic alteplase
Sample Package No

Linked Drug Pages (1)

Cathflo Activase ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "0c2938dd-2978-411f-bd76-208fc8754838", "openfda": {"unii": ["1RXS4UE564"], "spl_set_id": ["91ecdef2-95ff-42dd-a31c-c8a09cab3ad9"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (50242-041-10)  / 2 mL in 1 VIAL", "package_ndc": "50242-041-10", "marketing_start_date": "20191014"}, {"sample": false, "description": "1 VIAL in 1 CARTON (50242-041-64)  / 2 mL in 1 VIAL", "package_ndc": "50242-041-64", "marketing_start_date": "20010904"}], "brand_name": "Cathflo Activase", "product_id": "50242-041_0c2938dd-2978-411f-bd76-208fc8754838", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "product_ndc": "50242-041", "generic_name": "Alteplase", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cathflo Activase", "active_ingredients": [{"name": "ALTEPLASE", "strength": "2.2 mg/2mL"}], "application_number": "BLA103172", "marketing_category": "BLA", "marketing_start_date": "20010904", "listing_expiration_date": "20271231"}